- Open Access
Management of intoxicated patients – a descriptive outcome analysis of 4,267 ICU patients
BMC Emergency Medicine volume 22, Article number: 38 (2022)
Intoxications are common in intensive care units (ICUs). The number of causative substances is large, mortality usually low. This retrospective cohort study aims to characterize differences of intoxicated compared to general ICU patients, point out variations according to causative agents, as well as to highlight differences between survivors and non-survivors among intoxicated individuals in a large-scale multi-center analysis.
A total of 105,998 general ICU patients and 4,267 individuals with the admission diagnoses “overdose” and “drug toxicity” from the years 2014 and 2015 where included from the eICU Collaborative Research Database. In addition to comparing these groups with respect to baseline characteristics, intensive care measures and outcome parameters, differences between survivors and non-survivors from the intoxication group, as well as the individual groups of causative substances were investigated.
Intoxicated patients were younger (median 41 vs. 66 years; p<0.001), more often female (55 vs. 45%; p<0.001), and normal weighted (36% vs. 30%; p<0.001), whereas more obese individuals where observed in the other group (37 vs. 31%; p<0.001). Intoxicated individuals had a significantly lower mortality compared to general ICU patients (1% vs. 10%; aOR 0.07 95%CI 0.05-0.11; p<0.001), a finding which persisted after multivariable adjustment (aOR 0.17 95%CI 0.12-0.24; p<0.001) and persisted in all subgroups. Markers of disease severity (SOFA-score: 3 (1-5) vs. 4 (2-6) pts.; p<0.001) and frequency of vasopressor use (5 vs. 15%; p<0.001) where lower, whereas rates of mechanical ventilation where higher (24 vs. 26%; p<0.001) in intoxicated individuals. There were no differences with regard to renal replacement therapy in the first three days (3 vs. 4%; p=0.26). In sensitivity analysis (interactions for age, sex, ethnicity, hospital category, maximum initial lactate, mechanical ventilation, and vasopressor use), a trend towards lower mortality in intoxicated patients persisted in all subgroups.
This large-scale retrospective analysis indicates a significantly lower mortality of intoxicated individuals compared to general ICU patients.
Intoxications are common, hence responsible for a large number of emergency ward presentations and subsequent intensive care admissions . Despite the large quantity of intoxicated individuals, the actual count of patients requiring monitoring is limited and the number of severe courses and deaths is comparatively low [2, 3]. As per the American Association of Poison Control Center´s annual report, 2,148,141 exposures to poison in humans were observed in the United States (US) in 2019, whereas only in 40,058 cases (1.8%) a major effect by the toxin on an individual’s outcome was observed. In contrast, 1,923 deaths (0.09%) due to poisoning were registered. In total, 658,242 poisoned patients were treated in US health-care facilities, of which 96,483 (14.6%) were admitted to an intensive care unit (ICU) . According to the Global Burden of Disease Study, 86,400 deaths worldwide (0.15% of all deaths) were caused by poisoning in 2015 .
Overall, there are many studies on poisoning in the medical literature, but only few involve large case numbers. Two of the largest papers in the field from the years 2008 to 2011 deal with European patient collectives and show a comparatively low in-hospital mortality in this very often heterogeneous group of patients (1-2%) [1, 2]. Furthermore, there are many studies on various specific toxins or local investigations of individual intensive care units examining distinct characteristics of causing substances and/or affected patients. The topics of these studies range from large multi-center studies, national health care cost analyses, biomarker validation studies to highly specific topics such as workup of Scorpion envenomation cases [6,7,8]. With this study, we sought not only to examine a large U.S. intensive care database in terms of outcome, but also to compare the outcome of the subgroup of intoxicated patients with the rest of all intensive care individuals in the same collective at the same time. Furthermore, we also tried to contrast not only epidemiological characteristics but also patient-care specific data of the two groups, and then compare in detail survivors and non-survivors of intoxicated patients, as well as the groups of each causative agent based on the same characteristics, to get a better picture of this heterogeneous diagnostic group.
The well-known problem is that only a small proportion of intoxicated patients are truly critically ill or at least require monitoring. Considering the limited availability and high costs of ICU beds, it is important to perform resource allocation appropriately without endangering human lives .
Several steps are necessary to counteract these problems. First, the population of intoxicated patients in intensive care units must be accurately characterized and their outcome analyzed. Further, it is necessary to develop prediction models in large cohorts that ideally filter out all patients who are likely to suffer from a complicated clinical course. Subsequently, these models have to be tested prospectively and possible pitfalls have to be learned from their application in practice. Finally, the models can be incorporated into routine procedures. In our analysis from multiple U.S. intensive care units, we seek to contribute important data to the first step. We provide an overview of a large cohort of general ICU patients (n=105,998) in the database compared with all intoxicated patients (n=4,267). Thereafter, we present a detailed analysis regarding survivors and non-survivors, as well as differences with regard to individual substance categories.
Critically ill patients admitted to an ICU were included in this analysis from the multi-centre eICU Collaborative Research Database . In accordance with national legislation and institutional requirements, written informed consent was not required for participation as this is an analysis of a publicly available, deidentified database with pre-existing institutional review board (IRB). An Institutional Review Board (IRB; Massachusetts Institute of Technology, Cambridge, MA, USA) approval was obtained for the creation of the database. The present study is an analysis of the publicly available anonymized database; therefore no further ethics approval was deemed necessary. The eICU database includes admissions of 335 ICUs across the USA in 2014 and 2015 and is released under the Health Insurance Portability and Accountability Act (HIPAA) safe harbor provision [10, 11]. Patients were classified by trained eICU clinicians according to Acute Physiology And Chronic Health Evaluation (APACHE) IV model . Only unique admissions of adult patients with available APACHE IV but no readmissions were included in the final analysis. In total 110,265 patients from the eICU database were included in the overall analysis, whereas intoxicated patients (n=4,267; diagnosis categories “drug toxicity” and sub-categories of "overdose") were looked at in detail.
Baseline characteristics were extracted, continuous data expressed as median ± interquartile range, and differences between independent groups calculated accordingly using Kruskal-Wallis equality rank test. Categorical data are expressed as numbers (percentages), and the chi-square test was used to calculate univariate differences between groups. In addition to standard laboratory parameters, relevant intensive care measures (mechanical ventilation; use of vasopressors; dialysis in the first three days) were extracted from the database. We used acute kidney injury (AKI) within the first 48 hours (according to Kidney Disease Improving Global Outcomes (KDIGO) definition), ICU mortality and hospital mortality as outcome parameters. Multilevel logistic regression with the ICU unit as random effect and overdose versus all other diagnoses as fixed effect was used to calculate adjusted odds ratios (aOR) with respective 95% confidence intervals (95%CI). Additionally, we conducted multivariable adjustment for age, sex, SOFA score and ethnicity. We chose these covariables based on our clinical experience. In a sensitivity analysis (with the subgroups: sex, age categories, ethnicity (Caucasian vs. Non-Caucasian), teaching vs. non-teaching hospitals, maximum lactate day 1 (< or ≥2.0 mmol/l), mechanical ventilation and vasopressor use), hospital mortality of intoxicated versus all other ICU patients was compared. Stata/IC 16.1 (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC) was used for all statistical analyses.
Characteristics of intoxicated versus other ICU patients
Regarding baseline characteristics, intoxicated patients were younger (median (IQR): 41 (29-53) yrs. vs. 66 (54-77) yrs.; p<0.001), as well as significantly more often female (55 vs. 45%; p<0.001). There was also a non-significant difference with regard to body mass indices (BMI) with more normal weighted patients in the “intoxication group” (36% vs. 30%) to more obese individuals in the other group (37 vs. 31%; p<0.001). More Caucasian (83 vs. 78%) and fewer African American (8 vs. 12%; p<0.001) patients were observed in the “intoxication group”. Intoxicated patients were also "healthier" in terms of disease severity according to common intensive care scores (sequential organ failure assessment/SOFA; and Acute Physiology and Chronic Health Evaluation/APACHE-IV), and laboratory parameters (blood counts, creatinine and lactate). The frequency of vasopressor use (5 vs. 15%; p<0.001) was lower, while rates of mechanical ventilation were higher (24 vs. 26%; p<0.001) in intoxicated subjects. There were no differences regarding dialysis in the first three days (3 vs. 4%; p=0.26). Accordingly, a significant difference for all outcome parameters was observed. A detailed list of all parameters is given in Table 1.
The odds for hospital mortality were lower in intoxicated patients (aOR 0.07 95%CI 0.05-0.11; p<0.001), a finding which persisted after multivariable adjustment for age, sex, ethnicity and SOFA score (aOR 0.17 95%CI 0.12-0.24; p<0.001).
This finding was confirmed for the entire subgroup analysis in terms of type of hospital (non-teaching OR 0.05 CI 0.03-0.09; teaching OR 0.14 CI 0.08-0.23), age (<65 years OR 0.10 CI 0.07-0.16; 65-79 years OR 0.10 CI 0.03-0.29; >79 years OR 0.06 CI 0.01-0.46), ethnicity (Caucasian OR 0.07 CI 0.05-0.11; non-Caucasian OR 0.07 CI 0. 03-0. 17), maximum lactate at day 1 (<2.0mmol/L OR 0.08 CI 0.03-0.16; ≥2.0mmol/L OR 0.11 CI 0.06-0.18), mechanical ventilation (no MV OR 0.05 CI 0.02-0.11; MV OR 0. 07 CI 0.05-0. 11), sex (female OR 0.05 CI 0.03-0.09; male OR 0.09 CI 0.06-0.15), and vasopressor use (no vasopressor use OR 0.06 CI 0.04-0.12; vasopressor use OR 0.18 CI 0.11-0.31). In Fig. 1, the results of the subgroup analysis regarding mortality in intoxicated versus all other ICU patients are shown by means of a forest plot.
Comparison of survivors and non-survivors of intoxicated patients
Regarding baseline characteristics of survivors and non-survivors, there was a numerical but no statistically significant difference for age (median (IQR): 41 (29-53) years in survivors; 48 (30-60) years in non-survivors; p=0.32), as well as for sex (55% female patients in survivors vs. 41% in non-survivors; p=0.27). Non-survivors were more often under- or normally weighted and less often overweighted or obese according to the World Health Organization (WHO) classification (see Table 2). Disease severity assessed by intensive care scores was higher in non-survivors (median SOFA: 8 vs. 3 pts.; APACHE-IV: 90 vs. 37 pts.). Also, patients in this group showed higher initial lactate (median 3.1 vs. 1.6 mmol/L; p<0.001), and serum creatinine values (median 1.3 vs. 0.8 mg/dL; p<0.001), as well as significantly higher leucocyte counts (median 13.0 vs. 8.6 G/l; p<0.001). In survivors, alcohols were observed as causative substances more frequently (12 vs. 0%), whereas non-survivors more often took street drugs (e.g. opiates, cocaine and amphetamine; 34 vs. 20%). Regarding outcome measures, higher rates of AKI (9 vs. 2%, p=0.047) and longer ICU stays were observed in non-survivors (see Table 2).
Comparison of different substance categories
As for causative substances, individuals with drug toxicity were significantly older (median age 70 vs. 37-44 years in all other groups; p<0.001), whereas for all other categories most patients were <65 years old (90-96% vs. 41%; p<0.001). In particular, analgesics, antidepressants, sedatives and drug toxicity were more frequently observed in women, and alcohol and street drugs were more common in men (see Table 3). Regarding BMI categories, a significant difference was found especially for alcohols with more normal weighted and less obese patients. Relevant differences were also found with regard to ethnicity. A detailed list of the specific differences can be found in Table 3. In terms of disease severity by means of APACHE-IV, the lowest scores were observed for analgesics (30 pts.), whereas the highest scores were found for drug toxicity (55 pts.; p<0.001). As for laboratory values, the highest lactate values on day 1 were found in alcohols (median 2.1 vs. 1.4-1.8 mmol/L; p<0.001), while the highest serum creatinine values were found in the drug toxicity group (median 1.1 vs. 0.8-0.9 mg/dL; p<0.001). The lowest rates of mechanical ventilation were observed in analgesics and drug toxicity (13 and 11% vs. 25-30% in all other groups; p<0.001), whereas patients with drug toxicity needed vasopressors significantly more often (17% vs. 2-6%; p<0.001). This group was also most likely to require dialysis within the first three days (13% vs. 2-6%; p=0.035). No significant differences were observed for outcome between AKI and mortality (see Table 3). Regarding length of stay, the shortest stays were found in the alcohols-group (median 24 hours), the longest in the drug toxicity-group (median 34 hours; p<0.001).
Using a large cohort of over 100,000 ICU patients, this study demonstrates that intoxicated individuals have a better short-term outcome than patients with other critical illnesses regardless of initial lactate, as well as various baseline (age, sex, ethnicity), and patient care characteristics (level of care, mechanical ventilation, vasopressor use). Since intoxications can be caused by a vast variety of substances and poisoned patients present with a wide range of clinical manifestations, they have always been a challenge for acute care physicians. Despite the etiologic diversity and relatively high general prevalence of intoxicated patients in ICUs, the need for invasive measures is comparatively rare. This analysis is intended to provide further important data regarding specific patient characteristics of intoxicated patients, and in particular those individuals who have a poor outcome, in order to help to identify them early in terms of better resource allocation.
In general, we observed a significantly lower mortality of intoxicated patients compared to the entire remaining collective. It is certainly not without reason that “intoxication” is described in current resuscitation guidelines as "reversible cause" and usually represents an acute event with comprehensible pathophysiology and clinical course, frequently also without relevant pre-existing (chronic) organ damage . With regard to outcome parameters, we found "less ill" patients in the intoxication group. Despite from similar rates of dialysis in the first three days, less patients suffered from AKI in the group of intoxicated patients. This is in accordance to our clinical experience, since the elimination of many substances can be accelerated with hemodialysis and/or –filtration . A somewhat surprising finding is the higher proportion of women with acute poisoning, as a greater proportion of men in this patient population is frequently described in the literature . A possible explanation could be intentional overdose (which is observed more frequently in women in contrast to e.g. exposure to chemicals) and high rates of sedatives as causative substances in our population which are used more often by female individuals . However, Brandenburg et al. observed a similar finding in their large-scale analysis on intoxicated patients, as well as a likewise relatively young average age of patients . Also, male patients had a numerically worse outcome compared to their female counterparts. This finding cannot be explained causally on the basis of the available data. Intoxicated patients in our study had lower BMIs, whereas underweighted patients within this group had worse outcomes. In the past a higher mortality in underweighted individuals has been observed in several medical conditions, as well as in the general population [15, 16]. In contrast, obese patients often show better outcomes, which is also known as the “obesity paradox”. The causes for weight-related outcome differences are complex and range from severe pre-existing chronic diseases, different drug distribution patterns of especially lipophilic substances, over nutritional status, socioeconomic factors up to immunological phenomenons [15,16,17]. For an accurate assessment of BMI-related outcomes, a standardized nutritional assessment, a detailed analysis of pre-existing conditions, but also a functional analysis regarding activities of daily life (ADLs) would be necessary. Unfortunately, we couldn’t obtain these data for this patient population, although the thesis-generating nature of the statement seems valuable. As for ethnicity, we observed a statistically significant difference between intoxicated and other ICU patients (more Caucasian patients in the “Intoxicated” group) as well as in-between groups of different causative substances (see Table 3), but not for mortality. In general, ethnic differences in drug overdose mortality have been observed in the US in the past . Thus a lower mortality among Caucasian patients, but increasing mortality among African American and Hispanic individuals was observed, yet also co-involvement of other drugs varies with ethnicity . Overall, for such an analysis, a distinction must be made between prescribed and illegal opioids, for example, and co-involvement of other substances has to be investigated. Yet we cannot provide a clear explanation for our findings as an analysis for causality is too complex and beyond the scope of this study. In general, age-group stratified, socioeconomic, educational and media-triggered factors must be considered as well . We also found a marked difference for initial serum lactate in survivors compared to non-survivors. This finding has been described in the past, but the proportion of deceased patients in our cohort is too small to calculate optimal cut-offs and risk groups . Especially in the group of patients intoxicated with alcohols, a high initial lactate was observed. This can be explained by an altered mitochondrial metabolism with reduced utilization in both acute and chronic alcoholism . However, this group showed the best outcome, which highlights the importance of initial serum lactate in the other groups. With regard to further laboratory parameters, relevant differences were shown for all blood count parameters. The lowest hemoglobin values were found in the drug toxicity group, as well as a higher median serum creatinine. A possible explanation could be the significantly higher age of these patients. The lowest platelet counts were found in the “alcohols group”. Harmful alcohol consumption is often associated with qualitative and quantitative disturbances of platelet integrity . Another interesting finding is that in two groups (“drug toxicity” and “street drugs”) significantly higher leukocyte counts were observed. In general, the frequent occurrence of idiopathic leukocytosis after use of stimulant drugs (so called “uppers”) has been described in the past, especially for amphetamines . With regard to higher leukocyte counts in the “drug toxicity” group, a causal explanation is again not possible in the absence of precise data regarding the causative substances. In general, a variety of drugs can cause leukocytosis, whereas a sole delimitation of infectious causes by leukocytosis is not possible in the absence of other laboratory parameters . It is also interesting to note that patients with “drug toxicity” had the highest proportion of vasopressor use and dialysis in the first three days, but a zero percent short term mortality. In contrast, significantly more mechanically ventilated patients were found in the "sedatives" and "street drugs" subgroups, with these individuals again contributing the highest numerical proportion of non-survivors. This possibly underlines the need for reversibility of intoxication, as mechanical ventilation per se is a known and relatively invasive ICU measure and independent predictor of ICU mortality .
This large-scale retrospective analysis shows a significantly better outcome of intoxicated individuals compared to general ICU patients. In general, a very low mortality rate is observed in this patient collective. Yet, it is difficult to find the right balance between a sufficiently cautious approach regarding monitoring and safe outpatient- or low-level care in clinical routine. Risk stratification tools and scores are absolutely necessary to enable sufficient resource allocation in the future. Therefore, clearly structured and coherent data acquisition is essential. Further studies should generally focus on pre-existing functional and nutritional status, as well as its causes in and effects on the critically ill, but also intoxicated patients.
Strengths and limitations
The great strength of this study is certainly the large number of included patients and the real-world character of the data. The main limitation of this study is its purely retrospective and observational character and the comparatively low number of deceased patients. This also prevents the use of an exact matching process. Also, the study only involves U.S. patients - in other countries, the results could be different. Since the eICU database uses the admission diagnoses according to APACHE IV, some patients may have been misclassified (e.g. "coma of unknown origin"). Due to the retrospective nature of the study, this issue cannot be excluded. Unfortunately, we do not have information on the location where the poisoning occurred (household, workplace, etc.), which might allow a better understanding of some data. Also, a more precise characterization of non-survivors (Invasiveness of measures, duration of ventilation, etc.) would be desirable. Nevertheless, we think that this large-scale study on more than 4,000 intoxicated individuals is a relevant contribution to the outcome assessment of intoxicated patients and can be thesis-generating for future studies.
Availability of data and materials
The data supporting the findings of this study are freely available at https://eicu-crd.mit.edu/. These data are publicly available online (after registration and signing a data use agreement). All other data in this particular manuscript are available from the corresponding author (Prof. Christian Jung) upon reasonable request.
Acute coronary syndrome
Activities of daily life
Acute kidney injury
Acute Physiology And Chronic Health Evaluation
Acute respiratory failure
Body mass index
Coronary artery bypass grafting
Congestive heart failure
Intensive Care Unit
Length of stay
Sequential Organ Failure Assessment
World health organization
Lindqvist E, Edman G, Hollenberg J, Nordberg P, Forsberg S. Long-term mortality and cause of death for patients treated in Intensive Care Units due to poisoning. Acta Anaesthesiol Scand. 2019;63(4):500–5.
Brandenburg R, Brinkman S, de Keizer NF, Meulenbelt J, de Lange DW. In-hospital mortality and long-term survival of patients with acute intoxication admitted to the ICU. Crit Care Med. 2014;42(6):1471–9.
Brandenburg R, Brinkman S, de Keizer NF, Kesecioglu J, Meulenbelt J, de Lange DW. The need for ICU admission in intoxicated patients: a prediction model. Clin Toxicol (Phila). 2017;55(1):4–11.
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al. 2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58(12):1360–541.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.
Lionte C, Bologa C, Sorodoc V, Petris OR, Puha G, Stoica A, et al. Biomarkers of inflammation and inflammation-related indexes upon emergency department admission are predictive for the risk of intensive care unit hospitalization and mortality in acute poisoning: a 6-year prospective observational study. Dis Markers. 2021;19(2021):4696156.
van Beusekom I, Bakhshi-Raiez F, de Keizer NF, de Lange DW. The healthcare costs of intoxicated patients who survive ICU admission are higher than non-intoxicated ICU patients: a retrospective study combining healthcare insurance data and data from a Dutch national quality registry. BMC Emerg Med. 2019;19(1):6.
Bouaziz M, Bahloul M, Kallel H, Samet M, Ksibi H, Dammak H, et al. Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in South Tunisia: multivariate analysis of 951 cases. Toxicon. 2008;52(8):918–26.
Abu Al-Saad N, Skedgel C, Nortje J. Principles of resource allocation in critical care. BJA Education. 2017;17(12):390–5.
Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Scientific Data. 2018;5(1):180178.
O’Halloran HM, Kwong K, Veldhoen RA, Maslove DM. Characterizing the Patients, Hospitals, and Data Quality of the eICU Collaborative Research Database. Crit Care Med. 2020;48(12):1737–43.
Lott C, Truhlář A, Alfonzo A, Barelli A, González-Salvado V, Hinkelbein J, et al. European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation. 2021;161:152–219.
Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The Role of Renal Replacement Therapy in the Management of Pharmacologic Poisonings. International Journal of Nephrology. 2016;2016:e3047329.
NIDA (National Institute on Drug Abuse). Sex and Gender Differences in Substance Use [Internet]. [cited 2021 Jun 17]. Available from: https://www.drugabuse.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use
Roh L, Braun J, Chiolero A, Bopp M, Rohrmann S, Faeh D, et al. Mortality risk associated with underweight: a census-linked cohort of 31,578 individuals with up to 32 years of follow-up. BMC Public Health. 2014;14(1):371.
Oami T, Karasawa S, Shimada T, Nakada T-A, Abe T, Ogura H, et al. Association between low body mass index and increased 28-day mortality of severe sepsis in Japanese cohorts. Sci Rep. 2021;11(1):1615.
Ng PY, Eikermann M. The obesity conundrum in sepsis. BMC Anesthesiology. 2017;17(1):147.
Cano M. Racial/ethnic differences in US drug overdose mortality, 2017–2018. Addictive Behaviors. 2021;112:106625.
Manini AF, Kumar A, Olsen D, Vlahov D, Hoffman RS. Utility of serum lactate to predict drug-overdose fatality. Clin Toxicol (Phila). 2010;48(7):730–6.
Yang C-C, Chan K-S, Tseng K-L, Weng S-F. Prognosis of alcohol-associated lactic acidosis in critically ill patients: an 8-year study. Sci Rep. 2016;6:35368.
Silczuk A, Habrat B. Alcohol-induced thrombocytopenia: Current review. Alcohol. 2020;86:9–16.
Richards JR, Farias VF, Clingan CS. Association of Leukocytosis with Amphetamine and Cocaine Use. Sci World J. 2014;22(2014):e207651.
Abramson N, Melton B. Leukocytosis: Basics of Clinical Assessment. AFP. 2000;62(9):2053–60.
Mamandipoor B, Frutos-Vivar F, Peñuelas O, Rezar R, Raymondos K, Muriel A, et al. Machine learning predicts mortality based on analysis of ventilation parameters of critically ill patients: multi-centre validation. BMC Med Inform Decis Making. 2021;21(1):152.
Open Access funding enabled and organized by Projekt DEAL.
Ethics approval and consent to participate
In accordance with national legislation and institutional requirements, written informed consent was not required for participation as this is an analysis of a publicly available, deidentified database with pre-existing institutional review board (IRB). An Institutional Review Board (IRB; Massachusetts Institute of Technology, Cambridge, MA, USA) approval was obtained for the creation of the database. The present study is an analysis of the publicly available anonymized database; therefore no further ethics approval was deemed necessary. The eICU database includes admissions of 335 ICUs across the USA in 2014 and 2015 and is released under the Health Insurance Portability and Accountability Act (HIPAA) safe harbor provision
Consent for publication
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Rezar, R., Jung, C., Mamandipoor, B. et al. Management of intoxicated patients – a descriptive outcome analysis of 4,267 ICU patients. BMC Emerg Med 22, 38 (2022). https://doi.org/10.1186/s12873-022-00602-y
- Hospital mortality
- Intensive care units
- Critical illness